Session 33

Friday, April 26, 2:00 – 3:30 pm
Auditorium Lindbergh

Esophagitis and Barrett's esophagus
Chairs: Dhanpat Jain (USA) – Rupert Langer (France) 
 

1. What is the clinical significance of making a diagnosis of sloughing esophagitis? – Dhanpat Jain (USA) 
2. What is the clinical significance of making a diagnosis of lymphocytic esophagitis? – Monika Tripathi (Canada) 
3. What is the clinical significance of making a diagnosis of lichenoid esophagitis? – Maryam K. Pezhouh (Canada) 
4. What are the similarities and differences between lymphocytic and eosinophilic esophagitis? – Sara Hafezi Bakhtiari (Canada) 
5. Is there any role of counting eosinophils in EOE patients? – Maryam K. Pezhouh (USA) 
6. Is there any significance in reporting sub-epithelial fibrosis on biopsies in EOE patients? – Kevin M. Waters (USA) 
   Q&A
    
7. Should goblet cells be required for the diagnosis of Barrett's esophagus? – Maha Guindi (USA) 
8. What is diagnostic and prognostic role of p53 IHC in BE and dysplasia? – Huang Qin (USA) 
9. What are the common challenges in evaluating margins for dysplasia and cancer in esophageal EMR/ESD? – Deyali Chatterjee (USA) 
10. What is the current status of AI and ML application in Barrett's esophagus? – Sara Hafezi Bakhtiari (Canada) 
    Q&A